Camden National Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-80,191
Closed -$7.41M – 172
2024
Q2
$7.41M Buy
80,191
+9,845
+14% +$872K 1.14% 45
2024
Q1
$6.72M Sell
70,346
-519
-0.7% -$43.6K 1.19% 42
2023
Q4
$5.4M Sell
70,865
-2,420
-3% -$168K 1.01% 48
2023
Q3
$5.08M Buy
73,285
+149
+0.2% +$12K 1.04% 47
2023
Q2
$6.9M Sell
73,136
-653
-0.9% -$56.8K 1.35% 33
2023
Q1
$6.1M Buy
73,789
+678
+0.9% +$53.3K 1.24% 38
2022
Q4
$5.46M Sell
73,111
-2,289
-3% -$176K 1.14% 43
2022
Q3
$6.23M Buy
75,400
+277
+0.4% +$26.7K 1.39% 32
2022
Q2
$7.14M Buy
75,123
+688
+0.9% +$71.2K 1.48% 25
2022
Q1
$8.76M Sell
74,435
-163
-0.2% -$18.3K 1.59% 22
2021
Q4
$9.66M Sell
74,598
-1,068
-1% -$125K 1.7% 17
2021
Q3
$8.57M Sell
75,666
-751
-1% -$85.7K 1.65% 21
2021
Q2
$7.91M Sell
76,417
-1,556
-2% -$147K 1.49% 25
2021
Q1
$6.52M Buy
77,973
+709
+0.9% +$59.9K 1.3% 37
2020
Q4
$7.05M Sell
77,264
-2,130
-3% -$177K 1.47% 28
2020
Q3
$6.34M Buy
79,394
+48,274
+155% +$3.77M 1.4% 29
2020
Q2
$2.15M Buy
+31,120
New +$2.21M 0.53% 52

Other funds holding EW

Camden National Bank's EW Position: Q3 2024 in Review

Camden National Bank sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 80,191 shares — an estimated $7.41M sold.

Camden National Bank first reported a position in EW in Q2 2020 and held it in 17 quarters. The position peaked at $9.66M in Q4 2021. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Camden National Bank reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Camden National Bank sold 80,191 Edwards Lifesciences shares in Q3 2024, an estimated $7.41M.
  • Camden National Bank first reported a position in Edwards Lifesciences in Q2 2020 and held it in 17 quarters.
  • Camden National Bank's Edwards Lifesciences position peaked at $9.66M in Q4 2021.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Camden National Bank's 13F filing for Q3 2024, filed 12 Nov 2024.